PKTX · ProtoKinetix, Inc.
$0.00
At close · Aug 27
Going-concern doubt
— flagged Nov 13, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern. The Company needs additional working capital to continue its medical research or to be successful in any future business activities and continue to pay its liabilities. Therefore, continuation of the Company as a going concern is dependent upon obtaining the additional working capital necessary to accomplish its objective. Management is presently engaged in seeking additional working capital through equity financing or related party loans.”View the 10-Q filed Nov 13, 2025
Market Cap
$78,316
Shares
391.58M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Clarence E. Smith | President & CEO | $1,920,866 |
| Michael R. Guzzetta | Chief Financial Officer | $931,461 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Clarence E. Smith | President & CEO | $941,688 |
| Michael R. Guzzetta | Chief Financial Officer | $575,147 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Keith Brunt | president of the Company | Appointed | 2026-06-17 |
| Keith Brunt | director | Appointed | 2026-06-17 |
| Jason Lamp | directors of the Company | Appointed | 2026-06-17 |
| Michael Jones | directors of the Company | Appointed | 2026-06-17 |
| Edward McDonough | Board of Directors | Resigned | 2026-06-17 |
| Michael Guzzetta | President and Chief Executive Officer | Appointed | 2025-11-17 |
| Michael Guzzetta | Chairman of the Board of Directors | Appointed | 2025-11-17 |
| Clarence E. Smith | member of the Board of Directors | Terminated | 2025-11-17 |
| Edward McDonough | director | Appointed | 2022-02-14 |
| Clarence Smith | director | Appointed | 2022-02-14 |